Liquid collagen injections are used to mainly remove wrinkles from facial skin. However, injected collagen and all non-permanent tissue fillers are absorbed in 1-6 months, limiting the benefit of the wrinkle treatment and leading to frequent re-injections. CosmetaLife™, made of tiny injectable gel-particles configured to simulate skin, can provide a longer lasting treatment and a natural dermal correction by rejuvenating the skin to diminish, ameliorate, and repair the wrinkle through healing mechanisms.

Gel-Del® is focused on bringing CosmetaLife™, its superior product for wrinkle treatment to the cosmetic augmentation market by the fourth quarter of 2008. This market already generates about $1 billion of annual revenue and is growing every year at increasing rates with little more than mediocre products (2003-04 increased 35%). Gel-Del's business plan includes the formation of the subsidiary Cosmeta™Corp, a cosmetic biomaterials company that designs and produces cosmetic augmentation products. After the CosmetaLife™ launch, Cosmeta™Corp expects to develop additional products in the cosmetic augmentation marketplace.